104
Participants
Start Date
August 5, 2015
Primary Completion Date
March 6, 2018
Study Completion Date
March 6, 2018
Sertraline or venlafaxine
Patients were treated as needed with sertraline or venlafaxine following the official guidelines, starting with a dose of 25 mg/d or respectively 37,5 mg/day. The starting dose could be increased during the course of the treatment as clinically needed according to guide lines.
Immune parameters
Serum was taken before, during an after treatment for measurement of different immune parameters.
University of Bordeaux
OTHER
IRCCS Centro San Giovanni di Dio Fatebenefratelli
OTHER
Ruhr University of Bochum
OTHER
National Research Agency, France
OTHER
Créteil Hospital
OTHER
German Federal Ministry of Education and Research
OTHER_GOV
Ministry of Health, Italy
OTHER_GOV
Kliniken Essen-Mitte
OTHER